The transgenic overexpression of tomoregulin-1 increased the survival rate (Fig. 4), improved the cardiac geometry and functional parameters of echocardiography (Fig. 5), decreased the degree of cardiac hypertrophy (Fig. 5), and reduced collagen accumulation in the interstitial space of the TAC mice (Fig. 6). This evidence concerns the gene TMEFF1 and cardiac hypertrophy.